Home › NDC Lookup › RxCUI directory › RxCUI 2667457

Capsaicin 0.00025 MG/MG / lidocaine 0.0475 MG/MG Medicated Patch — RxCUI 2667457

RxNorm drug concept · Semantic clinical drug
RxCUI 2667457 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 7 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2667457
Official nameCapsaicin 0.00025 MG/MG / lidocaine 0.0475 MG/MG Medicated Patch
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascapsaicin 0.025 % / lidocaine 4.75 % Medicated Patch
FDA products mapped6
Package NDCs mapped7
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lidocaine Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It relieves nerve pain from post-herpetic neuralgia, the lingering pain that can follow shingles. It is used in adults. It numbs the pain signals in the skin under the patch.
  • Usually up to 12 hours in a 24-hour period, then 12 hours off. Put it on intact skin over the most painful spot. Do not use more patches than prescribed.
  • No. Heat can increase how much lidocaine gets absorbed. With Ztlido, you can apply a patch after brief heat, but never put a heating pad or electric blanket directly on it.
  • For Ztlido, light exercise and short water exposure, like a 10-minute shower, are okay. Gently pat it dry rather than rubbing. If the edges lift, press them down.
📖 Read our full Lidocaine Transdermal Patch guide →

🕸️ Concept Web — How Capsaicin 0.00025 MG/MG / lidocaine 0.0475 MG/MG... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Capsaicin 0.00025 MG/MG / lidocaine 0.0475 MG/MG Medicated Patch RxCUI 2667457

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Capsaicin 1992
    • Lidocaine 6387
    • Capsaicin / lidocaine 1008338
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Capsaicin / lidocaine Medicated Patch 2667456
    • Capsaicin / lidocaine Topical Product 1155433
    • Medicated Patch 1792831
    • Topical Product 1151122
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Capsaicin 0.00025 MG/MG 329253
    • Lidocaine 0.0475 MG/MG 2667455

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Capsaicin 0.00025 MG/MG SCDC · 329253
  • Lidocaine 0.0475 MG/MG SCDC · 2667455
  • Capsaicin / lidocaine Medicated Patch SCDF · 2667456
  • Capsaicin / lidocaine Topical Product SCDG · 1155433

📦 FDA Products & Package NDCs

6 products · 7 package NDCs
7 package NDCs map to RxCUI 2667457 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
68788-8599-03 8 POUCH in 1 BOX (68788-8599-3) / 4 PATCH in 1 POUCH / 2.7... Trubrexa Preferred Pharmaceuticals Inc. 2024-03-15
72189-0541-11 2.7 g in 1 PATCH (72189-541-11) Trubrexa Patch ER Direct_Rx 2024-03-11
76420-0644-32 8 POUCH in 1 BOX (76420-644-32) / 4 PATCH in 1 POUCH / 2.7... Trubrexa Asclemed USA, Inc. 2023-12-13
80425-0367-01 8 POUCH in 1 BOX (80425-0367-1) / 4 PATCH in 1 POUCH / 2.7... Trubrexa Advanced Rx Pharmacy of Tennessee, LLC 2023-11-27
83295-4000-01 8 POUCH in 1 BOX (83295-4000-1) / 4 PATCH in 1 POUCH / 2.7... Trubrexa Strand Health Group 2023-10-03
83295-4000-04 4 PATCH in 1 POUCH (83295-4000-4) / 2.7 g in 1 PATCH Trubrexa Strand Health Group 2023-10-03
85509-4000-03 8 POUCH in 1 BOX (85509-4000-3) / 4 PATCH in 1 POUCH / 2.7... Trubrexa PHOENIX RX LLC 2025-07-20
Observed labelers: Strand Health Group (2) · Advanced Rx Pharmacy of Tennessee, LLC (1) · Asclemed USA, Inc. (1) · Direct_Rx (1) · PHOENIX RX LLC (1) · Preferred Pharmaceuticals Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.